13/12/2025
ADA 2026 emphasizes combination therapy for diabetic neuropathy, and the most evidence-based combinations are:
🔹 Pregabalin + Duloxetine
🔹 Gabapentin + Duloxetine
🔹 Pregabalin/Gabapentin + Amitriptyline
🔹 Gabapentinoid + Topical agent (Lidocaine or Capsaicin)